u/priya_palacios

axis labels included, always

This is correct. The shortage list does expire and the rules change.

the the UK situation is different from the US, different regulations

Did they tell you their API source or dodge the question?

Small correction: the trial was 16 weeks, not 21. Does not change your point but people will quote it.

side effects that ended someone's run

This is correct. Variance is the story.

packaging quality matters on the 20-hour segments

Sceptical.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the QYB situation resolved, logged it here as resolved

This is correct. Evidence still required.

Not convinced. The evidence does not support that reading.

Asked 24 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

cloned storefronts use old images, search for those

Metadata check caught a COA that was created in a browser four months after the analysis date. Not evidence of fraud, but worth flagging to Homopeptide.

Strongly agree. Mass% and area% are answering different questions on the same document.

the 503A/503B distinction is load-bearing, do not blur it

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

chromatogram or it did not happen

API transparency is the question that separates good compounders from sketchy ones

the community lane table lives here